We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Predictive factors for interstitial lung disease, antitumor response, and survival in non-small-cell lung cancer patients treated with gefitinib.
- Authors
Ando, Masahiko; Okamoto, Isamu; Yamamoto, Nobuyuki; Takeda, Koji; Tamura, Kenji; Seto, Takashi; Ariyoshi, Yutaka; Fukuoka, Masahiro
- Abstract
Interstitial lung disease (ILD) is a serious adverse effect of gefitinib, but its prevalence and risk factors remain largely unknown. We examined the prevalence of and risk factors for gefitinib-induced ILD associated with practical use of the drug in Japanese with non-small-cell lung cancer (NSCLC).
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Vol 24, Issue 16, p2549
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2005.04.9866